Reaction
Autoimmune Myocarditis reporting signals
As of the last recalculation, Autoimmune Myocarditis appears in 216 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is NIVOLUMAB (PRR 82.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nivolumab | 60 | 82.4 | 82.5 |
| Pembrolizumab | 54 | 65.6 | 65.6 |
| Ipilimumab | 24 | 60.2 | 60.2 |
| Axitinib | 7 | 35.8 | 35.8 |
| Pemetrexed | 7 | 32.5 | 32.5 |